|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$749.42 |
$752.20 |
$743.77 |
$745.95 |
1.72M | 04/19/2024 |
$749.16 |
$750.01 |
$722.07 |
$726.31 |
3.51M | 04/22/2024 |
$729.74 |
$737.88 |
$725.42 |
$731.33 |
2.35M | 04/23/2024 |
$741.20 |
$746.16 |
$731.44 |
$745.69 |
2.04M | 04/24/2024 |
$752.64 |
$752.64 |
$728.79 |
$732.20 |
2.13M |
|
Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products and other therapies. Co.'s diabetes products include: Basaglar®, a long-acting human insulin analog for the treatment of diabetes; and Trajenta®, for the treatment of type 2 diabetes. Co.'s oncology products include: Alimta®, for treatment of patients with non-squamous cell histology and no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations. | |
|
Eli Lilly (LLY) has the following price history information. Looking back at LLY historical stock prices for the last five trading days, on April 18, 2024, LLY opened at $749.42, traded as high as $752.20 and as low as $743.77, and closed at $745.95. Trading volume was a total of 1.72M shares. On April 19, 2024, LLY opened at $749.16, traded as high as $750.01 and as low as $722.07, and closed at $726.31. Trading volume was a total of 3.51M shares. On April 22, 2024, LLY opened at $729.74, traded as high as $737.88 and as low as $725.42, and closed at $731.33. Trading volume was a total of 2.35M shares. On April 23, 2024, LLY opened at $741.20, traded as high as $746.16 and as low as $731.44, and closed at $745.69. Trading volume was a total of 2.04M shares. On April 24, 2024, LLY opened at $752.64, traded as high as $752.64 and as low as $728.79, and closed at $732.20. Trading volume was a total of 2.13M shares.
LLY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Eli Lilly shares, starting with a $10,000 purchase of LLY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$58.97 |
|
End price/share: |
$732.20 |
|
Starting shares: |
169.58 |
|
Ending shares: |
209.00 |
|
Dividends reinvested/share: |
$28.52 |
|
Total return: |
1,430.27% |
|
Average Annual Total Return: |
31.37% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$152,980.95 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$58.97 |
|
End price/share: |
$732.20 |
|
Dividends collected/share: |
$28.52 |
|
Total return: |
1,190.02% |
|
Average Annual Total Return: |
29.15% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$129,014.86 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $745.95 | 04/19/2024 | $726.31 | 04/22/2024 | $731.33 | 04/23/2024 | $745.69 | 04/24/2024 | $732.20 |
|
|